Survival and Complications of Beta-Thalassemia in Lebanon

被引:23
|
作者
Charafeddine, K.
Isma'eel, H.
Charafeddine, M.
Inati, A. [2 ,3 ]
Koussa, S. [3 ]
Naja, M.
Taher, A. [1 ,3 ]
机构
[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon
[2] Rafik Hariri Univ Hosp, Beirut, Lebanon
[3] Chron Care Ctr, Hazmieh, Lebanon
关键词
beta-Thalassemia; Lebanon; Complications; Survival;
D O I
10.1159/000171088
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
beta-Thalassemia major is a debilitating disease with a considerable incidence in Lebanon (around 2-3% carriership). The present article describes our experience to this day with 214 patients, emphasizing the survival of beta-thalassemia major and development of complications among patients with different parameters. Fifteen deaths were reported. The most common cause of death was heart failure (60%). Patients with a ferritin level of 3,000 ng/ml showed better survival than those with a level 1 3,000 ng/ml (p < 0.006). In addition, patients with a ferritin level of 1,500 ng/ml showed less complication-free survival than those with a level 1 1,500 ng/ml (p < 0.024). High level of ferritin (1,500 ng/ml) is associated with increased risk of heart failure. Overall and complication-free survival were statistically different among patients classified according to birth cohort or ferritin level. The Chronic Care Center, a multidisciplinary center located in the suburbs of Beirut, led to an increase in complication-free as well as overall survival. Although patients are being diagnosed earlier and chelation therapy is being initiated at an earlier age, complications due to iron overload still persist. The introduction of new oral iron chelators and better iron overload quantitation methods will most likely modify this picture, and a follow-up study will examine their impact. Copyright (C) 2008 S. Karger AG, Basel
引用
收藏
页码:112 / 116
页数:5
相关论文
共 50 条
  • [41] Pulmonary hypertension in a patient with beta-thalassemia major
    Mérault, JM
    Escamilla, R
    Degano, B
    Guittard, J
    Hermant, C
    Krempf, M
    REVUE DES MALADIES RESPIRATOIRES, 2000, 17 (03) : 689 - 691
  • [42] Finger and palmar dermatoglyphics in beta-thalassemia patients
    Bhalla, A. K.
    Marwaha, R. K.
    Kaur, Harvinder
    Sharma, Anju
    MANKIND QUARTERLY, 2007, 47 (03) : 57 - 74
  • [43] RETROCRURAL MASSES OF EXTRAMEDULLARY HEMATOPOIESIS IN BETA-THALASSEMIA
    VLAHOS, L
    TRAKADAS, S
    GOULIAMOS, A
    PLATANIOTIS, G
    PAPAVASILIOU, C
    MAGNETIC RESONANCE IMAGING, 1993, 11 (08) : 1227 - 1229
  • [44] Prenatal diagnosis in beta-thalassemia: An Indian experience
    Agarwal, S
    Gupta, A
    Gupta, UR
    Sarwai, S
    Phadke, S
    Agarwal, SS
    FETAL DIAGNOSIS AND THERAPY, 2003, 18 (05) : 328 - 332
  • [45] Contemporary approaches to treatment of beta-thalassemia intermedia
    Taher, Ali T.
    Musallam, Khaled M.
    Karimi, Mehran
    Cappellini, Maria D.
    BLOOD REVIEWS, 2012, 26 : S24 - S27
  • [46] REGIONAL DISTRIBUTIONS OF BETA-THALASSEMIA MUTATIONS IN TURKEY
    ATALAY, EO
    CIRAKOGLU, B
    DINCOLC, G
    ATALAY, A
    KILINC, Y
    AYTEKIN, H
    YUREGIR, GT
    ARPACI, A
    BERMEK, E
    AKSOY, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1993, 57 (03) : 207 - 211
  • [47] Intraocular pressure in subjects with beta-thalassemia minor
    Keskek, Sakir Ozgur
    Keskek, Nedime Sahinoglu
    Ilgin, Gizem
    Sukgen, Emine
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2019, 82 (03) : 220 - 224
  • [48] BLOOD-TRANSFUSION IN BETA-THALASSEMIA MAJOR
    REBULLA, P
    TRANSFUSION MEDICINE, 1995, 5 (04) : 247 - 258
  • [49] Genotypes and phenotypes of beta-thalassemia in Mediterranean populations
    Kattamis, C
    Kattamis, AC
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1997, 14 (03) : R7 - R9
  • [50] Selenium and glutathione peroxidase with beta-thalassemia major
    Bartfay, WJ
    Bartfay, E
    NURSING RESEARCH, 2001, 50 (03) : 178 - 183